Evidence map›Paper›PMID 42746341›Full record

ArticleJournal of skin cancer2026

Melanoma Severity at Presentation and Prior Skin Cancer Screening: A Survey Study of Surgical Oncology Patients.

Arnar B Ingason, Venkatesa P Muruganandam, Melanie Bui, Jessica Cintolo-Gonzalez

Abstract read
In one paragraph

Article in Journal of skin cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arnar B IngasonDivision of Surgical Oncology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA, uvm.edu.ORCID https://orcid.org/0000-0003-0943-2523
Venkatesa P MuruganandamDivision of Surgical Oncology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA, uvm.edu.ORCID https://orcid.org/0000-0002-2875-9145
Melanie BuiDivision of Dermatology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA, uvm.edu.ORCID https://orcid.org/0009-0007-4131-3790
Jessica Cintolo-GonzalezDivision of Surgical Oncology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA, uvm.edu.ORCID https://orcid.org/0000-0003-0572-5265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The effectiveness of population-based melanoma screening remains uncertain. However, most melanomas continue to present outside of skin cancer screening, underscoring the need to better understand and serve unscreened populations. Methods: All patients presenting to surgical oncology at a rural tertiary referral center with newly diagnosed invasive melanoma from April 2020 to January 2021 were administered a survey to assess history of a skin cancer screening examination and risk factors for melanoma. Additional demographic and clinical characteristics were abstracted from the electronic medical record. The exposure of interest was dermatological skin cancer screening examination within the past 12 months. The primary outcome was pathological tumor staging. This was assessed using ordinal logistic regression. Results: Forty patients presented to surgical oncology with a newly diagnosed melanoma. Thirty patients (75%) reported no skin cancer screening examination within the past 12 months. Patients who had screening were more likely to report prior indoor tanning use (70% [7/10] vs. 23% [7/30], OR 7.20, 95% CI 1.25-55.24, Conclusions: Most melanomas presenting to surgical oncology occurred in patients without recent screening and were more advanced at presentation. These findings highlight the importance of maintaining rapid access to dermatologic evaluation for patients who do not participate in routine screening, as they represent the majority of clinically significant melanoma presentations.

Indexed as

dermatologic screeningfull-body skin examinationmalignant melanomascreening

Identifiers

PMID42746341
PMCPMC13575876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.